Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · January 14, 2024

Association of PIK3CA Mutation With Outcomes in Patients With Early-Stage ERBB2/HER2-Positive Breast Cancer

JAMA Network Open


Additional Info

JAMA Network Open
Association of PIK3CA Mutation With Pathologic Complete Response and Outcome by Hormone Receptor Status and Intrinsic Subtype in Early-Stage ERBB2/HER2-Positive Breast Cancer
JAMA Netw Open 2023 Dec 01;6(12)e2348814, P Zagami, A Fernandez-Martinez, NU Rashid, KA Hoadley, PA Spears, G Curigliano, CM Perou, LA Carey

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading